ACET
ACET
NASDAQ · Biotechnology

Adicet Bio Inc

$6.90
+0.09 (+1.32%)
As of Apr 1, 3:25 PM ET ·
Financial Highlights (FY 2025)
Revenue
5.25M
Net Income
1.19M
Gross Margin
35.9%
Profit Margin
22.6%
Rev Growth
+6.7%
D/E Ratio
0.59
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 35.9% 35.9% 35.9%
Operating Margin 30.8% 34.6% 35.7%
Profit Margin 22.6% 27.2% 23.3%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 5.25M 5.50M 4.94M
Gross Profit 1.88M 1.97M 1.77M
Operating Income 1.62M 1.90M 1.76M
Net Income 1.19M 1.50M 1.15M
Gross Margin 35.9% 35.9% 35.9%
Operating Margin 30.8% 34.6% 35.7%
Profit Margin 22.6% 27.2% 23.3%
Rev Growth +6.7% -8.7% -5.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 21.83M 18.52M 18.45M
Total Equity 37.26M 35.31M 37.42M
D/E Ratio 0.59 0.52 0.49
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 2.24M 2.36M 2.10M
Free Cash Flow 844.4K 896.3K 789.1K